The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...

To that end, Florida Tech has relaunched the underutilized Center for Advanced Manufacturing and Innovative Design as Vertex, a new "applied innovation hub." Rather than function as a traditional ...

Drivers were facing long delays on the M60 following three incidents this morning. There were long queues on the M60 anticlockwise due to a broken down vehicle. Two lanes of traffic were closed ...

A FOUR-CAR crash sparked rush-hour chaos on the M60 this morning with huge queues and hour-long delays. Two lanes closed near to junction 24 at Denton Island on the M60 clockwise with traffic ...

Queues were building up on part of the M60 following a crash. Three lanes of traffic were closed on the M60 clockwise this afternoon (February 17). It followed an incident near junction 16 at Clifton.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...